Lone Star Neurology

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Migraine4 trials
• Multiple sclerosis2 trials

Phase

• Phase 35 trials
• Phase 21 trial

Status

• Active, not recruiting5 trials
• Completed1 trial

Lead sponsor

• Ipsen3 trials
• Amgen1 trial
• Novartis Pharmaceuticals1 trial
• Tian Medical Inc.1 trial

Running trials

• Active, not recruiting

  Comparison Between ABP 692 and Ocrevus® (Ocrelizumab)

  NCT06700343· Phase 3· Amgen· Source

• Active, not recruiting

  A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults

  NCT06625060· Phase 2· Ipsen· Source

• Active, not recruiting

  A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Chronic Migraine in Adults

  NCT06047444· Phase 3· Ipsen· Source

• Active, not recruiting

  A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Episodic Migraine in Adults

  NCT06047457· Phase 3· Ipsen· Source

• Active, not recruiting

  Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)

  NCT05156281· Phase 3· Novartis Pharmaceuticals· Source

Closed trials

• Completed

  Efficacy and Safety of Tx360® Transnasal Sphenopalatine Ganglion Block in the Treatment of Chronic Migraine

  NCT03337620· Phase 3· Tian Medical Inc.· Source